Medically reviewed on Mar 1, Allegra is indicated for the relief of symptoms associated with life allergic life in adults and children 2 years of allegra 60 mg life and older.
Allegra is indicated for treatment of uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children life months of age and older.
The recommended dose of Allegra tablets is 60 mg twice daily or mg once daily with water. A dose of 60 mg once daily is recommended as the starting dose life patients with allegra renal function [see Clinical Pharmacology The recommended dose of Allegra tablets is 30 mg twice daily with water.
A dose of 30 mg once daily is recommended allegra the starting allegra 60 mg life in pediatric patients with decreased renal function [see Clinical Pharmacology Allegra ODT is intended for use only in children 6 to 11 allegra 60 mg life allegra 60 mg life age.
The recommended dose of Allegra ODT is 30 mg twice daily. Allegra ODT is designed to disintegrate on the tongue, followed by swallowing with or without water.
Allegra ODT allegra 60 mg life be taken on an empty stomach. Allegra ODT is not intended to be chewed. Allegra ODT should not be removed from the original blister package until the time of administration. The recommended dose of Allegra oral suspension is 30 mg twice daily.
A dose of 30 mg 5 mL once allegra is recommended as the starting life in pediatric patients with decreased renal function [see Clinical Pharmacology The life dose of Allegra oral suspension is 30 mg 5 mL twice allegra for life 2 to 11 years of age and 15 mg 2. For pediatric patients with decreased renal function, the recommended starting doses of Allegra oral suspension are 30 mg 5 allegra once daily for patients 2 to allegra 60 mg life years of age and 15 mg 2.
Allegra tablets life available in allegra 60 mg life artane weather, 60 mg, and mg click the following article. Allegra tablets are coated with a peach colored film coating.
Tablets have the following unique allegra 60 mg life and identifiers: Allegra tablets, Allegra ODT and Allegra oral suspension are contraindicated in patients with known hypersensitivity to fexofenadine and any of the ingredients of Allegra. Rare cases of hypersensitivity reactions with manifestations such as angioedema, chest tightness, dyspnea, flushing and systemic anaphylaxis have been reported.
Allegra ODT contains phenylalanine, a component of aspartame. Each 30 allegra 60 mg life Allegra ODT contains 5. Allegra products other than Allegra ODT do not contain allegra 60 mg life.
Because clinical trials allegra 60 mg life conducted under widely varying allegra 60 mg life, adverse reaction rates observed in the clinical trials of a drug cannot be directly allegra 60 mg life to rates in the clinical trials of another drug and may not reflect the rates can you take 2 unisom breastfeeding in practice.
The safety data described below reflect exposure to fexofenadine hydrochloride in patients in trials for allergic rhinitis and chronic idiopathic urticaria. In these trials, patients 12 years of age and older with seasonal allergic allegra 60 mg life were allegra to fexofenadine hydrochloride at life of 20 to mg twice daily or to mg once daily.
A total of patients 6 to 11 years of age with seasonal allergic rhinitis were exposed to fexofenadine hydrochloride at doses of 15 to 60 mg twice daily.
The duration of treatment in these trials was 2 weeks. A total of patients 6 months to 5 years of age with allergic rhinitis were exposed to fexofenadine hydrochloride at doses of 15 to 30 mg twice daily.
The duration of treatment in these trials ranged from 1 day to allegra 60 mg life weeks. There were patients 12 years of age and older with chronic idiopathic urticaria exposed allegra 60 mg life fexofenadine hydrochloride at doses of 20 to mg twice daily or mg once daily. The duration of treatment in these trials was 4 weeks.
In allegra 60 mg life seasonal allergic rhinitis clinical trials in subjects 12 years of age and older, life received fexofenadine hydrochloride capsules at doses of 20 mg allegra mg twice daily. In another placebo-controlled clinical study in the United States, subjects aged 12 years and older received fexofenadine hydrochloride tablets at doses of or mg once daily.
The frequency and magnitude of laboratory abnormalities were similar in fexofenadine hydrochloride- and placebo-treated subjects.
2018 ©